TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
CABA

Cabaletta Bio Inc

Healthcare · Biotechnology

1.40$ -5.3% vs. previous close Closing price · As of: Nov 2, 2026

Ownership

Ownership Structure

Who owns Cabaletta Bio Inc (CABA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 83.4% of the shares are freely tradable; institutional investors hold 63.6%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 63.6%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 1.0%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 83.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 25.1%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 170Mio.

Largest Shareholders

Institutions

Institutions CABA
Name Stake (%) Shares Change (%) Date
Jennison Associates LLC 11.82 20,033,730 +123.3 06/30/2026
T. Rowe Price Investment Management,Inc. 11.13 18,869,907 +70.3 06/30/2026
Bain Capital Life Sciences Investors, LLC 10.17 17,241,445 +78.2 06/30/2026
BlackRock Inc 6.34 10,754,701 +353.2 06/30/2026
Adage Capital Partners Gp LLC 5.41 9,174,758 +3.9 06/30/2026
State Street Corp 4.62 7,839,305 +1,568.0 06/30/2026
Vanguard Capital Management, LLC 4.26 7,227,018 +79.4 06/30/2026

Funds

Funds CABA
Name Stake (%) Shares Change (%) Date
T. Rowe Price Small-Cap Value 4.95 8,397,995 +10.0 09/30/2026
PGIM Jennison Health Sciences Z 4.19 7,100,015 +43.1 09/30/2026
Vanguard MStar Total Stk Mkt Idx Invest 3.08 5,215,188 +0.0 09/30/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?